Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WNT1 | P04628 | 5/20 | 0.73 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.62 |
| ▸ | CLK2 | P49760 | 15/20 | 0.59 |
| ▸ | DYRK1A | Q13627 | 15/20 | 0.59 |
| ▸ | CLK3 | P49761 | 14/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18447146 | 0.94 | WNT1 (0.71) | WNT1TGFBR1CLK2DYRK1ACLK3 | |
| SCHEMBL18450904 | 0.92 | WNT1 (0.63) | WNT1TGFBR1CLK2DYRK1ACLK3 | |
| SCHEMBL18441350 | 0.91 | WNT1 (0.77) | WNT1TGFBR1CLK2DYRK1ACLK3 | |
| SCHEMBL20455004 | 0.91 | WNT1 (0.73) | WNT1TGFBR1CLK2DYRK1ACLK3 | |
| SCHEMBL20452574 | 0.90 | WNT1 (0.73) | WNT1TGFBR1CLK2DYRK1ACLK3 | |
| SCHEMBL18448781 | 0.90 | WNT1 (0.71) | WNT1TGFBR1CLK2DYRK1ACLK3 | |
| SCHEMBL18442345 | 0.90 | CLK2 (0.65) | WNT1TGFBR1CLK2DYRK1ACLK3 | |
| SCHEMBL18447750 | 0.89 | WNT1 (0.60) | WNT1TGFBR1CLK2DYRK1ACLK3 | |
| SCHEMBL18448409 | 0.89 | CLK2 (0.62) | WNT1TGFBR1CLK2DYRK1ACLK3 | |
| SCHEMBL15306964 | 0.89 | WNT1 (0.79) | WNT1TGFBR1CLK2DYRK1ACLK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017024013-A1 | 3-(1H-PYRROLO[2,3-C]PYRIDIN-2-YL)-1H-INDAZOLES AND THERAPEUTIC USES THEREOF | SAMUMED, LLC. (US) | 2017-02-09 | — | — | WO | claimed |
| WO-2017024013-A1 | 3-(1H-PYRROLO[2,3-C]PYRIDIN-2-YL)-1H-INDAZOLES AND THERAPEUTIC USES THEREOF | SAMUMED, LLC. (US) | 2017-02-09 | — | — | WO | disclosed |